Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,457 | 46,812 | 47,324 | 55,307 | 64,439 |
| Marketable Securities | 154,945 | 145,204 | 125,414 | 114,198 | 91,958 |
| TOTAL | $203,478 | $199,813 | $176,994 | $173,703 | $161,280 |
| Non-Current Assets | |||||
| PPE Net | 69,405 | 69,005 | 71,705 | 81,993 | 83,771 |
| Investments And Advances | 73,767 | 58,396 | 89,637 | 115,325 | 145,136 |
| Intangibles | 38,391 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 31,405 | 21,293 | 22,355 | 26,530 | 26,972 |
| TOTAL | $212,968 | $148,694 | $183,697 | $223,848 | $255,879 |
| Total Assets | $416,446 | $348,507 | $360,691 | $397,551 | $417,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 350 | 491 | 584 | 705 | 744 |
| Accounts payable and accrued liabilities | 3,358 | 3,432 | 2,741 | 5,927 | 3,625 |
| Accrued Expenses | 11,095 | 7,532 | 10,149 | 9,932 | 7,856 |
| TOTAL | $19,163 | $16,065 | $17,846 | $20,435 | $19,161 |
| Non-Current Liabilities | |||||
| Long Term Debt | 20 | 20 | 56 | 201 | 361 |
| Deferred Revenues | 4,360 | 4,610 | 4,372 | 3,871 | 6,936 |
| Other Non-Current Liabilities | 62,025 | 44,251 | 46,658 | 45,535 | 40,833 |
| TOTAL | $175,179 | $154,559 | $158,095 | $157,886 | $150,427 |
| Total Liabilities | $194,342 | $170,624 | $175,941 | $178,321 | $169,588 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 84,716 | 82,847 | 64,818 | 59,835 | 59,765 |
| Common Shares | 8 | 6 | 6 | 6 | 6 |
| Retained earnings | -715,040 | -683,833 | -655,771 | -616,373 | -583,652 |
| Other shareholders' equity | -309 | -241 | 108 | -1,304 | -1,208 |
| TOTAL | $222,104 | $177,883 | $184,750 | $219,230 | $247,571 |
| Total Liabilities And Equity | $416,446 | $348,507 | $360,691 | $397,551 | $417,159 |